tiprankstipranks
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH

Compare Aurinia Pharmaceuticals (AUPH) vs. Competitors

2,111 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Aurinia Pharmaceuticals
$15.61
$2.08B
7.46
90.60%
2 Buy
2 Hold
0 Sell
Moderate Buy
BioCryst
$9.02
$2.26B
6.20
21.40%
8 Buy
0 Hold
0 Sell
Strong Buy
Celldex
$31.06
$2.07B
-6.98
78.71%
10 Buy
1 Hold
1 Sell
Strong Buy
MannKind
$2.50
$770.25M
-27.17
-50.20%
6 Buy
1 Hold
0 Sell
Strong Buy
Sarepta Therapeutics
$23.23
$2.44B
-3.16
-62.81%
7 Buy
13 Hold
5 Sell
Hold
Immunocore Holdings
$30.83
$1.56B
-19.61
4.76%
7 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AUPH
Aurinia Pharmaceuticals
15.61
8.02
105.67%
BCRX
BioCryst
9.02
2.23
32.84%
CLDX
Celldex
31.06
15.33
97.46%
MNKD
MannKind
2.50
-2.19
-46.70%
SRPT
Sarepta Therapeutics
23.23
-29.17
-55.67%
IMCR
Immunocore Holdings
30.83
4.55
17.31%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts